The US-based cannabis dispensary trades at $6.73 today, after closing yesterday at $6.59 and gaining 14.35 cents (2.18%).
United States FOMC Meeting Minutes is next today at 19:00 UTC.
Curaleaf's uptick comes amid good United States macroeconomic data released during the day — data for United States Core Durable Goods Orders published today at 13:30 UTC came out at 0.5%, beating projections of 0.1% and showing improvement over the preceding figure of -0.9%.
On the flip side, highly important Crude Oil Inventories data from United States beat analyst expectations of -1 million with a reading of -3.69 million.
Meanwhile, United States New Home Sales (Oct) came out at 632,000, while a consensus of analysts was expecting 570,000.
Curaleaf Holdings, Inc. made an initial breakout above its 5 day Simple Moving Average at $6.77, a potential indicator of a newly emerging bullish phase. Curaleaf broke through the $6.55 resistance and climbed above it 18 cents; next resistance level is at $6.7.
Overall, looking at the technical analysis landscape, it seems Curaleaf might continue pointing upwards in the short term.
Rallies can also be seen in other health care stocks, Anthem gained 2.71%, currently at $482.58. Novo Nordisk is up 1.5%. Abbott Laboratories added 1.24% to its value, now trading at $106.17.
Also worthy of note, United States FOMC Meeting Minutes is scheduled for today at 19:00 UTC.
Curaleaf hit a significant low of $4.65 around a month ago, but has since recovered 41.72%.